Skip to main content
Livermore
Livermore
ZHEN

Rock Point Advisors, LLC

SEC CIK
0001301540
Latest filing
Aug 6, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Rock Point Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
380
Value
$236.9K
% of portfolio
0.1%
Quarters held
11
Since Q3 2023
Holdings of REGN by Rock Point Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026380$236.9K0.1%00.0%UnchangedHolders
Q1 2026380$293.6K0.1%00.0%UnchangedHolders
Q4 2025380$293.3K0.1%00.0%UnchangedHolders
Q3 2025380$213.7K0.1%+380NewHolders
Q2 20250$00.0%−380−100.0%Sold outHolders
Q1 2025380$241.0K0.1%00.0%UnchangedHolders
Q4 2024380$270.7K0.1%00.0%UnchangedHolders
Q3 2024380$399.5K0.1%00.0%UnchangedHolders
Q2 2024380$399.4K0.1%00.0%UnchangedHolders
Q1 2024380$365.7K0.1%00.0%UnchangedHolders
Q4 2023380$333.8K0.1%−20−5.0%ReducedHolders
Q3 2023400$329.2K0.1%+400NewHolders